pharmaceuticals

• 

  3/18/2025

  Court Ruling in Regeneron v. Amgen: A Key Decision on Patent Infringement and Biologic Formulations

• 3/10/2025

  Patent Law and Drug Innovation: Federal Circuit Upholds Rejection of ImmunoGen’s Patent Application

• 12/10/2024

  Galderma v. Lupin: CAFC Weighs In on ANDA Infringement and the Doctrine of Equivalents

• 9/21/2024

  Federal Circuit Vacates District Court’s Surprise Patent Ineligibility Ruling in Astellas v. Sandoz